CHOLESTEROL LOWERING FOR ALL - A CLOSER LOOK

被引:15
作者
PALUMBO, PJ
机构
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1989年 / 262卷 / 01期
关键词
D O I
10.1001/jama.262.1.91
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:91 / 92
页数:2
相关论文
共 23 条
[1]  
AGNER E, 1983, ACTA MED SCAND, V214, P33
[2]   CHOLESTEROL AND MORTALITY - 30 YEARS OF FOLLOW-UP FROM THE FRAMINGHAM-STUDY [J].
ANDERSON, KM ;
CASTELLI, WP ;
LEVY, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (16) :2176-2180
[3]   BENEFICIAL-EFFECTS OF COMBINED COLESTIPOL-NIACIN THERAPY ON CORONARY ATHEROSCLEROSIS AND CORONARY VENOUS BYPASS GRAFTS [J].
BLANKENHORN, DH ;
NESSIM, SA ;
JOHNSON, RL ;
SANMARCO, ME ;
AZEN, SP ;
CASHINHEMPHILL, L .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (23) :3233-3240
[4]   15 YEAR MORTALITY IN CORONARY DRUG PROJECT PATIENTS - LONG-TERM BENEFIT WITH NIACIN [J].
CANNER, PL ;
BERGE, KG ;
WENGER, NK ;
STAMLER, J ;
FRIEDMAN, L ;
PRINEAS, RJ ;
FRIEDEWALD, W .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1986, 8 (06) :1245-1255
[5]  
CARLSON LA, 1972, LANCET, V1, P865
[6]  
CARLSON LA, 1985, ACTA MED SCAND, V218, P207
[7]  
DAYTON S, 1969, CIRCULATION S2, V40, P1
[8]   HELSINKI HEART-STUDY - PRIMARY-PREVENTION TRIAL WITH GEMFIBROZIL IN MIDDLE-AGED MEN WITH DYSLIPIDEMIA - SAFETY OF TREATMENT, CHANGES IN RISK-FACTORS, AND INCIDENCE OF CORONARY HEART-DISEASE [J].
FRICK, MH ;
ELO, O ;
HAAPA, K ;
HEINONEN, OP ;
HEINSALMI, P ;
HELO, P ;
HUTTUNEN, JK ;
KAITANIEMI, P ;
KOSKINEN, P ;
MANNINEN, V ;
MAENPAA, H ;
MALKONEN, M ;
MANTTARI, M ;
NOROLA, S ;
PASTERNACK, A ;
PIKKARAINEN, J ;
ROMO, M ;
SJOBLOM, T ;
NIKKILA, EA .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (20) :1237-1245
[9]   SCREENING ASYMPTOMATIC ADULTS FOR CARDIAC RISK-FACTORS - THE SERUM-CHOLESTEROL LEVEL [J].
GARBER, AM ;
SOX, HC ;
LITTENBERG, B .
ANNALS OF INTERNAL MEDICINE, 1989, 110 (08) :622-639
[10]   ISCHEMIC HEART DISEASE ATHEROSCLEROSIS AND LONGEVITY [J].
GOFMAN, JW ;
YOUNG, W ;
TANDY, R .
CIRCULATION, 1966, 34 (04) :679-+